Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0677-2013Class III

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2.0 Ca 1Mg .16.5GAL Catalog...

Fresenius Medical Care Renal Therapies Group, LLC / initiated 2012-11-26 / Terminated / root cause: manufacturing process

Fresenius Medical Care Holdings, Inc. began a recall of Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2.0 Ca 1Mg .16.5GAL Catalog Number: OFD2201-3B Product Usage: GranuFlo is... on . FDA classified it as Class III and gives the reason as "GranuFlo Dry Acid Concentrate may show discoloration". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0677-2013
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Fresenius Medical Care Renal Therapies Group, LLC
Product
Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2.0 Ca 1Mg .16.5GAL Catalog Number: OFD2201-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.
Product code
KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Reason for recall
GranuFlo Dry Acid Concentrate may show discoloration
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Fresenius Medical Care North America notified consignees by telephone on November 26, 2012 and follow-up letter on November 30, 2012 of the product recall. On January 10, 2013, the firm expanded there recall to an additional 32 lots (34 lots total). Customers were instructed to examine their inventory immediately, discontinue use, place all units in quarantine and return to Fresenius Medical Care North America. Customers were advised to contact their Fresenius Medical Care Customer Service Team for instructions on how to return the recalled product. For questions contact the GranuFio Recall Line at 1-888-803-0509
Quantity in commerce
17,782 units
Distribution
US Nationwide Distribution
Product codes and lots
Lot Numbers:12NXGF004, 12NXGF008, 12PXGF010, 12PXGF014

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0677-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0676-2013Class IIITerminatedVoluntary: Firm initiated
Z-0677-2013Class IIITerminatedVoluntary: Firm initiated
Z-0678-2013Class IIITerminatedVoluntary: Firm initiated
Z-0679-2013Class IIITerminatedVoluntary: Firm initiated
Z-0680-2013Class IIITerminatedVoluntary: Firm initiated
Z-0681-2013Class IIITerminatedVoluntary: Firm initiated
Z-0682-2013Class IIITerminatedVoluntary: Firm initiated
Z-0683-2013Class IIITerminatedVoluntary: Firm initiated
Z-0684-2013Class IIITerminatedVoluntary: Firm initiated